Pulmatrix, Inc. (PULM)

NASDAQ: PULM · Real-Time Price · USD

1.270

+0.020 (1.60%)

May 13, 2026, 4:00 PM EDT - Market closed

Pulmatrix Earnings Call Transcripts

Fiscal Year 2024

M&A Announcement

The merger will create a Nasdaq-listed biotech with a strong cash position, focused on advancing Cullgen's targeted protein degrader and DAC pipeline. Pulmatrix stockholders will retain a small stake and potential asset sale proceeds, while Cullgen's technology and collaborations drive future growth.

Read full transcript →

Slides

Powered by